Denmark's Lundbeck has said that efforts to build its R&D portfolio are on track to deliver four new molecular entities (NMEs ...

Crypto.com Arena, which celebrated its 25th anniversary this month, has completed phase three of its nine-figure, ...

Pharmaceuticals and Sobi announced that results from the Phase 3 VALIANT study were presented as an oral presentation during the High-Impact Clinical Trials session at the American Society of ...

Bitcoin’s (BTC) price has climbed 55% so far in 2024, including 12.50% gains in October. Its recent increases have been ...

The second phase of the project to refurbish the Kpong Irrigation Scheme (KIS) has begun, three years after the first phase ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company will present its pivotal Phase 3 data on ...

Enterprises are poised to take artificial intelligence to the next level, building on initial forays into AI that mostly ...

BriaCell Therapeutics could access a $1-$5 billion market upon approval despite a sub-$30 million cap. See more on BRIA stock ...

Wuthering Waves version 1.3 phase II is out now It brings a plethora of in-game events Version 1.3 previously introduced a ...

The UK’s competition regulator is investigating whether Alphabet’s $2.3 billion investment in AI startup Anthropic harms UK ...

With the market already anticipating record sales from Chinese automaker BYD Co., a convincing overseas growth story will be ...

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative cancer medicines, today announced that initial safety and ...